Unlock instant, AI-driven research and patent intelligence for your innovation.

mrgd immune antigen fragment, mrgd antibody and preparation method and application thereof

A technology for immunizing antigens and fragments, which is applied in immunoglobulins, chemical instruments and methods, and anti-animal/human immunoglobulins to achieve good specificity.

Active Publication Date: 2022-05-03
JIANGSU PROVINCE HOSPITAL THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the in vivo distribution and mechanism of MrgD have not yet been clarified. Therefore, if a method can be invented to quickly determine the distribution of MrgD in the body, it will be of great significance for the regulation of hypertension.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • mrgd immune antigen fragment, mrgd antibody and preparation method and application thereof
  • mrgd immune antigen fragment, mrgd antibody and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] 1. Polypeptide antigen synthesis

[0025] The following fragment was selected and synthesized from the rat MrgD sequence, SSPAPGLTISPTMDC, as the immune antigen.

[0026] 2. Animal immunization

[0027] Several New Zealand rabbits of 2-3 kg were immunized with the synthesized polypeptide antigen.

[0028] Initial immunization: Antigen 100ug / rat, plus complete Freund's adjuvant (antigen and adjuvant are mixed in equal volumes, ground into a water-in-oil chylus) and subcutaneously injected at multiple points on the back, with a volume of 1.5ml.

[0029] The second immunization: the second immunization was performed at an interval of 2 weeks after the initial immunization, the dosage route was the same as above, and incomplete Freund's adjuvant was added.

[0030] The third immunization: after the second immunization, the third immunization was carried out at an interval of 2 weeks. The dose was the same as above, without adjuvant, intraperitoneally injected, and blood w...

Embodiment 2

[0044] Rat primary cardiomyocytes were extracted, cultured in the medium DMEM+10% FBS for 48 hours, the medium was discarded, washed twice with PBS, fixed with 4% paraformaldehyde for 30 minutes, blocked with 5% BSA for 30 minutes, and added to the example The MrgD antibody obtained in step 1 was spent overnight at 4, and then washed 3 times with PBS, added fluorescent secondary antibody (cy3) and incubated at room temperature for 2 hours, eluted the secondary antibody, added anti-fluorescent quencher, mounted the slide and took pictures. Such as figure 1 As shown, it can be seen that the content of MrgD in normal cardiomyocytes is low.

Embodiment 3

[0046] Rat primary cardiomyocytes were extracted and added with angiotensin II (concentration 10 -6mol / L) culture medium DMEM+10% FBS for 24 hours, discard the medium, wash twice with PBS, fix with 4% paraformaldehyde for 30 minutes, block with 5% BSA for 30 minutes, add MrgD antibody for 4 nights, Then wash 3 times with PBS, add secondary antibody and incubate at 37°C for 1 hour, wash 3 times with PBS, mount the slides and take pictures. Such as figure 2 As shown, it can be seen that the expression level of MrgD (highlighted part) is higher in hypertrophic cardiomyocytes induced by angiotensin II.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of antibody preparation and application thereof, in particular to the preparation of monoclonal antibody and its application in immunofluorescence. This antibody can bind to rat Mas-associated G protein-coupled receptor D (MrgD), and has good specificity. Combined with immunofluorescence, it can quickly detect changes in the expression level of MrgD under cardiac pathological and physiological conditions. The occurrence and development process provides a reliable basis.

Description

technical field [0001] The invention relates to MrgD immune antigen fragments, MrgD antibodies and their preparation methods and applications, belonging to the field of biomedicine. Background technique [0002] Hypertensive diseases are increasing year by year, and the main hazards are target organ damage, including cardiovascular remodeling, stroke, renal failure, eye diseases, etc. The regulation of hypertension mainly includes hormone regulation and nerve regulation. The former is mainly renin-angiotensin system (RAS), and the latter is sympathetic-parasympathetic regulation. Studies have found that Mas-related G protein-coupled receptor D (MrgD) is the main receptor for the regulation of the renin-angiotensin system and plays an important role in the regulation of the renin-angiotensin system. However, the in vivo distribution and mechanism of MrgD have not been clarified. Therefore, if a method can be invented to quickly measure the distribution of MrgD in the body, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/72C07K16/28G01N33/68G01N33/58G01N33/577
CPCC07K14/723C07K16/2869G01N33/6893G01N33/582G01N33/577G01N2333/726G01N2800/321
Inventor 李鹏吴晓光赵锟毛宇康孔祥清
Owner JIANGSU PROVINCE HOSPITAL THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIV